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Dear Editor, 
We thank Rentoft and colleagues for commenting on our paper “Transcriptional profiling 
of oral squamous cell carcinoma using formalin-fixed paraffin-embedded samples”, and 
agreeing that formalin-fixed paraffin embedded (FFPE) tissue specimens can be used 
for gene expression studies using microarrays, to identify genes that are significantly 
involved in oral carcinogenesis. The similarities and high concordance between the 
study by Rentoft et al. [1] and ours [2] is comforting and clearly supports the use of 
FFPE tissues in such experiments. More importantly, these studies act as independent 
validation for one another and strongly suggests that genes that were found to be up- or 
down-regulated in oral squamous cell carcinoma (OSCC) do indeed play a role in these 
cancers and therefore warrant further investigation to determine their utility as 
biomarkers and therapeutic targets for OSCC. We wanted to point out however, that the 
similarities between these 2 studies are not completely unexpected despite previous 
reports highlighting that the concordance between microarray studies are hard to 
achieve [3]. The main disparities between datasets from microarray experiments have 
been attributed to the use of different microarray platforms and the heterogeneity of the 
tissue specimens that were used [4] and [5]. Indeed, many microarray studies reported 
for the head and neck, used tissues from several distinct areas which have been 
reported to be genetically heterogeneous, and associated with different aetiologies [6] 
and [7]. Given that both our studies used the DASL assay and tissues from the oral 
cavity (albeit from different sites-explained further below) the consistency of the genes 
that were identified should not come as a complete surprise. However, it is still intriguing 
that the similarities between these two studies were so close despite previous reports 
indicating that there are distinct differences between oral cancers associated with 
different aetiology [8] and [9], and reports describing the distinct genetic differences 
between subsites of the oral cavity [10], [11] and [12]. Our previous study describing the 
differences in gene-expression patterns between oral cancers associated with betel 
quid chewing and smoking demonstrated that despite the differences seen, genetic 
changes common to all the cancers were also observed suggesting that there are core 
events and pathways that are important regardless of the aetiology or site of the cancer 
[8]. Consistently, upon close examination of the genes that are most differentially 
expressed between our study and that of Rentoft et al. [1] 5 of the top 10 over-lapping 
genes most differentially expressed were matrix metalloproteinases, whilst other genes 
include IL-8, CXCL-9 and BCL2A1, genes that were consistently up-regulated in many 
other microarray studies of the head and neck independent of the subsites of cancer [8], 
[12], [13] and [14]. An unprecedented large overlap of genes between our study [2] and 
that of Rentoft and colleagues [1] may also be due to the smaller number of genes on 
the arrays that were used in these studies (502 genes), and that these genes were pre-
selected based on their involvement in cancer development, whereas the majority of 
previous studies used platforms consisting of larger arrays and hence could capture 
much more of the heterogeneity typically observed in cancers. More recently, Illumina 
launched its whole genome DASL assay and it would be interesting to see if the 
similarities between buccal and tongue cancers still prevails. In conclusion, increasing 
number studies including the 2 compared here, strongly supports the use of FFPE 
tissues for gene expression studies using microarrays. The development of new 
technologies and statistical methods that addresses the challenges associated with 
using FFPE tissues, combined with the clinical information available with these 
specimens, will indeed facilitate the identification and discovery of clinically relevant 
gene signatures and biomarkers and therapeutic targets to improve the management of 
cancers in general. 
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